Casirivimab-Imdevimab (REGN-COV2) for Mild-to-Moderate SARS-CoV2 Infection in Kidney Transplant Recipients. Academic Article uri icon

Overview

publication date

  • September 6, 2021

Identity

PubMed Central ID

  • PMC8418987

Digital Object Identifier (DOI)

  • 10.1016/j.ekir.2021.08.032

PubMed ID

  • 34514186